BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 15367620)

  • 21. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients.
    Bouchat S; Gatot JS; Kabeya K; Cardona C; Colin L; Herbein G; De Wit S; Clumeck N; Lambotte O; Rouzioux C; Rohr O; Van Lint C
    AIDS; 2012 Jul; 26(12):1473-82. PubMed ID: 22555163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapy.
    Equils O; Garratty E; Wei LS; Plaeger S; Tapia M; Deville J; Krogstad P; Sim MS; Nielsen K; Bryson YJ
    J Infect Dis; 2000 Sep; 182(3):751-7. PubMed ID: 10950768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
    Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
    Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.
    Chun TW; Stuyver L; Mizell SB; Ehler LA; Mican JA; Baseler M; Lloyd AL; Nowak MA; Fauci AS
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13193-7. PubMed ID: 9371822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
    Hermankova M; Siliciano JD; Zhou Y; Monie D; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
    J Virol; 2003 Jul; 77(13):7383-92. PubMed ID: 12805437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
    Sedaghat AR; Siliciano RF; Wilke CO
    BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.
    Chun TW; Engel D; Berrey MM; Shea T; Corey L; Fauci AS
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8869-73. PubMed ID: 9671771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes.
    Huang J; Wang F; Argyris E; Chen K; Liang Z; Tian H; Huang W; Squires K; Verlinghieri G; Zhang H
    Nat Med; 2007 Oct; 13(10):1241-7. PubMed ID: 17906637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication.
    Pomerantz RJ
    Clin Infect Dis; 2002 Jan; 34(1):91-7. PubMed ID: 11731950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
    Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs.
    Valea D; Tuaillon E; Al Tabaa Y; Rouet F; Rubbo PA; Meda N; Foulongne V; Bollore K; Nagot N; Van de Perre P; Vendrell JP
    Retrovirology; 2011 May; 8():34. PubMed ID: 21569457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons.
    Saavedra-Lozano J; McCoig C; Xu J; Cao Y; Keiser P; Ghetie V; Siliciano RF; Siliciano JD; Picker LJ; Ramilo O; Vitetta ES
    J Infect Dis; 2002 Feb; 185(3):306-14. PubMed ID: 11807712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
    Banga R; Procopio FA; Cavassini M; Perreau M
    J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.
    Siliciano JD; Kajdas J; Finzi D; Quinn TC; Chadwick K; Margolick JB; Kovacs C; Gange SJ; Siliciano RF
    Nat Med; 2003 Jun; 9(6):727-8. PubMed ID: 12754504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.
    Dornadula G; Nunnari G; Vanella M; Roman J; Babinchak T; DeSimone J; Stern J; Braffman M; Zhang H; Pomerantz RJ
    J Infect Dis; 2001 Jun; 183(11):1682-7. PubMed ID: 11343220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART.
    Calcaterra S; Cappiello G; Di Caro A; Garbuglia AR; Benedetto A
    J Infect; 2001 Nov; 43(4):239-45. PubMed ID: 11869061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenge of viral reservoirs in HIV-1 infection.
    Blankson JN; Persaud D; Siliciano RF
    Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
    Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
    J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.